logo
Sixteen states sue White House over healthcare access for transgender youth

Sixteen states sue White House over healthcare access for transgender youth

The Guardian4 days ago
Sixteen states are suing the Trump administration to defend transgender youth healthcare access, which has rapidly eroded across the US due to threats from the federal government.
The Democratic attorneys general of California, New York, Massachusetts, Illinois and Connecticut are leading the lawsuit, announced on Friday, which challenges the president's efforts to eradicate vital medical treatments for trans youth.
The complaint targets one of the president's first executive orders issued in January, which described puberty blockers and hormone therapy as 'chemical and surgical mutilation', called for federal funds to be withheld from hospitals that provide the treatments and suggested the US Department of Justice could investigate doctors. Those gender-affirming treatments, which are accessed by a small fraction of youth in the US, have for years been the standard of care endorsed by major US medical associations.
Under intensifying threats that hospitals could lose federal funding, and growing fears that providers could be criminally prosecuted, a number of major institutions have abruptly ended gender-affirming care for trans youth.
The crackdown has sent families scrambling for alternatives, including in blue states long considered sanctuaries for LGBTQ+ rights, where clinics and lawmakers had previously assured youth they would be shielded from Donald Trump's agenda.
Last month, Children's Hospital Los Angeles, one of the nation's largest and most prominent institutions to serve trans kids, shuttered its gender-affirming care center for youth after three decades, citing funding threats from across the federal government.
Other institutions that have recently pulled back gender-affirming care services for trans youth include Phoenix Children's Hospital in Arizona, Stanford Medicine, Denver Health, the University of Chicago, the University of Pennsylvania and Children's National Hospital in Washington DC. Some have ceased surgeries for patients under age 19, which are rare, while others have also ended hormone therapy and puberty blockers.
The justice department in July also announced that it had sent subpoenas to more than 20 doctors and clinics that provide gender-affirming care to youth, a move that sent shock waves among providers and raised alarms that patients' information could be shared with the federal government.
The suit notes the administration has already launched criminal investigations and explicitly threatened providers in California, Colorado and Massachusetts and that officials have 'demanded extensive data, including patient medical records'.
The blue states are also challenging a June memo from Brett Shumate, assistant US attorney general, which directed the justice department's civil division to 'use all available resources to prioritize investigations of doctors, hospitals, pharmaceutical companies and other appropriate entities' that provide gender-affirming care.
Republican lawmakers in more than 25 states have moved to restrict trans youth healthcare in recent years. But the treatments remain legal in other parts of the country, and states such as California have anti-discrimination laws that explicitly protect the services.
The plaintiffs argue that Trump's actions should be declared unlawful, alleging his order exceeds federal authority. California's attorney general, Rob Bonta, also challenged Trump's definition of children as people under the age of 19, affecting 18-year-old adults' access to care, saying the administration's directives force hospitals to violate state laws.
Bonta said denying this care has been shown to worsen mental health outcomes, including increased rates of depression, anxiety and suicidal ideation. 'Trump and Bondi are not trained medical professionals. They aren't at all qualified to give anyone medical advice. What's worse, they refuse to listen to the actual experts,' he said at a press conference.
Sign up to This Week in Trumpland
A deep dive into the policies, controversies and oddities surrounding the Trump administration
after newsletter promotion
Citing comments from one parent of a trans child treated at a center that is shutting down, Bonta said: 'This closure will be life and death for trans youth who can no longer get the care they need.'
'What would you do if your child was diagnosed with gender dysphoria? I would fight for my kid every single day,' added William Tong, the Connecticut attorney general. 'We're fighting for … parents who just want to do the best for their kids, as we all do, to help them live their best and truest lives.'
Joining the lawsuit are the attorneys general of Delaware, Hawaii, Maine, Maryland, Michigan, Nevada, New Jersey, New Mexico, Rhode Island and Wisconsin, along with the District of Columbia and the Pennsylvania governor.
The White House and justice department have been contacted for comment.
The suit comes after the US supreme court upheld Tennessee's ban on trans youth healthcare.
'Hormone therapy truly saves lives,' said Eli, a trans 16-year-old who lost his healthcare in Los Angeles, in a recent Guardian interview. 'I wish people understood they're doing so much more harm than they could possibly imagine – that so many lives will be hurt and lost and so many people torn apart.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable
Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable

The Independent

time21 minutes ago

  • The Independent

Pfizer CEO says pharmaceutical companies want to work with Trump to make medicine more affordable

Pfizer CEO Albert Bourla announced that major pharmaceutical companies are ready to work with the Trump administration to make medicines more affordable and directly available to consumers. This move comes after Trump demanded that 17 drugmakers expand direct-to-consumer options and lower prices to match those in other industrialized countries, threatening to use 'every tool' if they did not comply. Pfizer and Bristol Myers Squibb have already revealed plans to offer their blood thinner Eliquis at a lower price online, building on Pfizer's existing direct-to-consumer telehealth and prescription services. Other companies, such as Eli Lilly and Novo Nordisk, are also exploring direct access for their obesity drugs, aiming to bypass pharmacy benefit managers. Despite potential sector-specific tariffs on pharmaceutical imports, which could escalate to 250 percent, Pfizer expects to meet its financial forecasts, though experts have refuted Trump's claims of significant drug price reductions.

Trans doctor in nurse row lamented lack of guidelines on changing rooms
Trans doctor in nurse row lamented lack of guidelines on changing rooms

Times

time22 minutes ago

  • Times

Trans doctor in nurse row lamented lack of guidelines on changing rooms

The transgender doctor at the centre of a landmark tribunal over women-only spaces lamented the lack of clear guidelines about access to female changing rooms, documents have shown. Dr Beth Upton said NHS Fife potentially missed an opportunity to intervene before the incident involving the doctor and the nurse Sandie Peggie in a female changing room at Victoria Hospital in Kirkcaldy, Fife, on Christmas Eve 2023. Peggie has taken the health board and Upton to an employment tribunal claiming she faced discrimination and harassment as a result of being forced to share female changing rooms with the doctor, who is biologically male but identifies as female. Peggie confronted Upton in the women's changing rooms at the hospital's A&E department, telling Upton she believed the doctor had no right to be there. Upton lodged a formal complaint with the board, claiming to have been subjected to a transphobic 'hate incident', which led to Peggie being suspended for several months. Peggie is now suing the health board and Dr Upton for alleged sexual harassment, belief discrimination, and victimisation under the Equality Act 2010. A previously unpublished document among hundreds included in an evidence bundle for the tribunal reveals Upton raised the absence of a clear transgender policy at the internal Fife Health and Social Care Partnership disciplinary hearing into Peggie's conduct. • Janice Turner: Class snobbery is at heart of NHS gender war The HR representative Melanie Jorgensen asked Upton at the conduct hearing in June if there had been a missed opportunity for intervention by NHS Fife before the changing-room incident. The notes of the meeting state Upton said this was 'difficult to answer' and adds the doctor 'feels potentially there was a missed opportunity'. Upton told the hearing it was 'clear the organisation do not have a policy'. The notes continue: 'Beth Upton advised that she understands the legal side of things, but also feels a lot of this would have been easier if there had been a policy document that would have confirmed what to do in this situation.' Upton's comments come after the pivotal Supreme Court judgment in April that ruled women are defined by biological sex under equalities law. Trina Budge, director of For Women Scotland who brought the legal challenge to the Supreme Court, said: 'There absolutely should be a policy and it's unacceptable that they continue without one. 'This should have been dealt with as a priority after the Supreme Court judgment. 'The policy should have made it clear that men such as Dr Upton are not allowed in female changing rooms. 'It's just creating more disasters and more tribunals for the NHS — not just NHS Fife but throughout Scotland.' Fiona McAnena, director of campaigns for the human-rights charity Sex Matters, which advocates for clarity about biological sex in law and life, said: 'This shows the risks of changing policy on the fly in response to one trans-identifying person's request. • Sandie Peggie blames her upbringing for use of racial slurs 'A sign on a door saying 'Male' or 'Female' is already a statement of policy — that the space is for one sex only, in compliance with workplace regulations. 'That is what most people will understand the sign to mean. Employers are not free to choose a different meaning of 'single-sex', or a different interpretation of laws and statutory regulations. Every employer needs to follow the law as it stands.' A spokeswoman for NHS Fife previously said: 'Throughout the course of the employment tribunal, NHS Fife has been clear that it will not comment on individuals or evidence while legal proceedings are ongoing. 'We remain respectful of the legal process and the role of the tribunal in considering all evidence presented.' A Scottish government spokesman said: 'It would be inappropriate to comment further while judicial proceedings in an employment tribunal are ongoing.'

DaVita beats quarterly profit on steady demand for dialysis services
DaVita beats quarterly profit on steady demand for dialysis services

Reuters

timean hour ago

  • Reuters

DaVita beats quarterly profit on steady demand for dialysis services

Aug 5 (Reuters) - DaVita (DVA.N), opens new tab beat Wall Street estimates for second-quarter profit on Tuesday, driven by demand for its kidney dialysis services. The company provides kidney care services for patients with chronic kidney failure through a network of outpatient clinics and at-home dialysis across the United States. DaVita, which had been grappling with rising patient care and operating costs, has also experienced disruptions from hurricanes and a ransomware attack in April, which affected some of its operations. The company said its higher IT expenses and costs tied to the cybersecurity incident led to a 10% rise in general and administrative costs from the first quarter. Earlier in the day, DaVita's peer Fresenius Medical Care ( opens new tab missed quarterly profit expectations after a severe flu season in the U.S. led to higher mortality among patients and a greater number of missed treatments earlier this year. However, DaVita reported quarterly revenue of $3.38 billion, compared to analysts' estimates of $3.36 billion, according to LSEG data. The company said it benefited from seasonal factors, including more patients meeting their co-insurance and deductibles, meaning insurance kicked in to cover treatment costs. On an adjusted basis, DaVita reported a second-quarter profit of $2.95 per share for the quarter, above analysts' estimates of $2.77 per share.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store